Synapse - Thoracic Oncology

Results (3389)

Phase II trial of docetaxel and vinorelbine in advanced non-small cell lung cancer (NSCLS) with analysis of bcl-2 and bax expression

Meeting Abstract

Krug, L. M.; Filippa, D. A.; Kris, M. G.; Zelenetz, A.; Heelan, R. T.; Grant, S. C.; Ng, K. K.; Pizzo, B. A.; Miller, V. A.
Proceedings of the American Association for Cancer Research Annual Meeting (1999)

Fulltext@MSK | Save

Paclitaxel and carboplatin prior to surgery in early stage non-small cell lung cancer (NSCLC)

Meeting Abstract

Pisters, K. M. W.; Ginsberg, R. J.; Putnam, J. B.; Johnson, D. H.; Roberts, J. R.; Kris, M. G.; Crowley, J.; Bunn, P. A.
Seminars in Oncology (1999)

Fulltext@MSK | Save

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin (PDX), a new antifolate

Meeting Abstract

Krug, L. M.; Ng, K. K.; Miller, V. A.; Heelan, R. T.; Tong, W.; Kelly, J.; Sirotnak, F. M.; Kris, M. G.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by co-administration of ZD1839 (Iressa™), an inhibitor of EGF receptor tyrosine kinase

Meeting Abstract

Sirotnak, F. M.; Miller, V. A.; Scher, H. I.; Kris, M. G.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Phase I study of oral ZD1839 (Iressa™), a novel inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR-TK): Evidence of good tolerability and activity

Meeting Abstract

Kris, M.; Ranson, M.; Ferry, D.; Hammond, L.; Averbuch, S.; Ochs, J.; Rowinsky, E.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo